Pricing Log in Create free account

CytomX Therapeutics, Inc. (CTMX) vs Electra Therapeutics Inc. (ETRA)

CytomX Therapeutics, Inc. and Electra Therapeutics Inc. are both Biotechnology companies. CytomX Therapeutics, Inc. and Electra Therapeutics Inc. are of similar size ($466.3M and $461.3M).

Valuation

Metric CTMX ETRA Biotechnology median
P/E n/m — 10.60
P/S 34.21 — 9.40
P/B 1.68 — 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m — 0.66
EV/Sales 10.89 — 9.02
Earnings yield (22.83%) — (32.88%)
Free cash flow yield (10.61%) — (23.13%)

Profitability

Metric CTMX ETRA Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (676.45%) — 0.00%
Net margin (630.38%) — 0.00%
Free cash flow margin (362.89%) — 0.00%
Return on equity (45.08%) — (51.96%)
Return on assets (33.82%) — (46.06%)
Return on invested capital (20.82%) — 0.00%

Growth

Metric CTMX ETRA Biotechnology median
Revenue growth (TTM) (87.66%) — 6.76%
EPS growth (last fiscal year) (139.47%) — 29.88%
Revenue growth, 5-year CAGR (5.36%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CTMX ETRA Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 7.82 — 4.97
Net debt to EBITDA 5.91 — 1.01

Dividend

Metric CTMX ETRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTMX ETRA Biotechnology median
Market cap 466.30m 461.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack